Gluconic Acid

Gluconic Acid

SCHEMBL9017591

O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[MgH2]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A

The experimentally established mechanism targets of Gluconic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.95
LMNA P02545 2/20 0.64
USP2 O75604 1/20 0.58
SLCO1B1 Q9Y6L6 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.55
TDP1 Q9NUW8 1/20 0.52
TSHR P16473 2/20 0.50
CYP2C9 P11712 1/20 0.50
OR51E2 Q9H255 1/20 0.42
KDM4E B2RXH2 2/20 0.39
PGD P52209 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gluconic Acid SCHEMBL28022593 1.00 PDE4A (0.95) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL6536096 1.00 PDE4A (0.95) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL1532403 1.00 PDE4A (0.95) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL2592766 0.98 PDE4A (0.91) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL3411056 0.98 PDE4A (0.91) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL21462394 0.98 PDE4A (0.91) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL505646 0.98 PDE4A (0.91) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL1053478 0.98 PDE4A (0.91) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL14894063 0.98 PDE4A (0.91) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL27773853 0.98 PDE4A (0.91) PDE4ALMNAUSP2SLCO1B1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110520136-A For making the regenerated composition of multi-way albumin dialysis liquid and method containing carrier protein HEPA WASH GMBH 2019-11-29 CN claimed
CN-110040991-A A method of quickly preparing short cylinder sulfate hemihydrate calcium material using calcium sulphate dihydrate 东北大学 2019-07-23 CN claimed
CN-109833266-A Cosmetic composition 深圳市富可迪生物科技有限公司 2019-06-04 CN claimed
CN-105556030-B Method for treating chemical pulp with ozone in the presence of magnesium ions 乔治洛德方法研究和开发液化空气有限公司 2019-05-03 CN claimed
CN-109589298-A A kind of artemia eggs ghost dispersion liquid and its preparation process and application 水母娘娘海洋生物科技有限公司 2019-04-09 CN claimed
CN-109548950-A The polypeptide and its preparation process in a kind of aurelia source and application 水母娘娘海洋生物科技有限公司 2019-04-02 CN claimed
CN-108865582-A A method of reducing mulberry fruit wine volatile acid content 四川理工学院 2018-11-23 CN claimed
CN-108308599-A A kind of composite health care food of tonifying kidney and strengthening yang 汪盛华 2018-07-24 CN claimed
CN-105078819-B A kind of moisturizing spraying and preparation method thereof 广东幸美化妆品股份有限公司 2018-03-20 CN claimed
CN-107690284-A Spray drying 奇华顿股份有限公司 2018-02-13 CN claimed
CN-1735344-A Novel substituted benzimidazole dosage forms and methods of use thereof UNIV MISSOURI (US) 2006-02-15 CN claimed
CN-1698570-A Cosmetic compositions comprising at least one salt, at least one cyclodextrin, and at least one surfactant, and uses thereof OREAL (FR) 2005-11-23 CN claimed
CN-1606452-A Liquid compositions of modified factor VII polypeptides NOVO NORDISK HEALTHCARE AG (DK) 2005-04-13 CN claimed
CN-1596120-A Pharmaceutical composition for transnasal absorption DAIICHI SUNTORY PHARMA CO LTD (JP) 2005-03-16 CN claimed
CN-1551768-A Novel substituted benzimidazole dosage forms and methods of use thereof ����˹���ѧ���»� 2004-12-01 CN claimed
CN-1426302-A Method for treating brain, spinal cord and nerve injury HOFFMANN LA ROCHE (CH) 2003-06-25 CN claimed
CN-1076624-C Nasally administrable compositions DOTT CO LTD (JP) 2001-12-26 CN claimed
CN-1228708-A Peptide-containing drug compositions for oral administration DOTT CO LTD (JP) 1999-09-15 CN claimed
US-5500668-A INK JET PRINTING XEROX CORPORATION (US) 1996-03-19 US claimed
CN-1117874-A Nasally administrable compositions DOTT RESEARCH LAB (JP) 1996-03-06 CN claimed